Table 2 Summary of clinical results. Ratio of Planned Treatment Volumes (PTVs) against 10-phase gold standard as a function of target motion. The Dice score for each scenario is indicated in parenthesis (DSC)
Patient | Target Range | PTVGS | RFB | RFB-Aug | RAIP | RMIP |
|---|---|---|---|---|---|---|
No. | M (cm) | (cc) | ||||
1 | 1.3 | 223.9 | 0.94 (0.860) | 1.00 (0.916) | 0.85 (0.820) | 0.90 (0.835) |
2 | 0.3 | 24.5 | 1.11 (0.835) | 0.99 (0.942) | 0.91 (0.878) | 0.92 (0.909) |
3 | 1.1 | 124.2 | 0.83 (0.769) | 0.95 (0.906) | 0.82 (0.769) | 0.90 (0.815) |
4 | 0.7 | 27.6 | 1.20 (0.754) | 1.02 (0.915) | 0.94 (0.826) | 1.11 (0.782) |
5 | 1.6 | 24.8 | 0.79 (0.470) | 1.00 (0.848) | 0.75 (0.745) | 0.78 (0.776) |
6 | 1.4 | 23.0 | 0.91 (0.614) | 0.95 (0.848) | 0.91 (0.795) | 0.86 (0.768) |
7 | 0.8 | 61.8 | 1.12 (0.785) | 1.03 (0.874) | 0.90 (0.791) | 0.97 (0.872) |
8 | 0.9 | 21.4 | 1.19 (0.643) | 1.12 (0.809) | 0.77 (0.745) | 0.94 (0.853) |
9 | 2.2 | 63.4 | 0.66 (0.538) | 0.92 (0.894) | 0.80 (0.784) | 0.95 (0.853) |
10 | 0.9 | 109.6 | 1.07 (0.842) | 1.00 (0.928) | 0.89 (0.866) | 0.91 (0.872) |
11 | 0.5 | 23.1 | 0.82 (0.770) | 0.90 (0.888) | 0.69 (0.913) | 0.71 (0.690) |
12 | 1.1 | 51.5 | 1.18 (0.734) | 1.08 (0.874) | 0.92 (0.755) | 0.91 (0.848) |
13 | 1.3 | 29.8 | 1.34 (0.690) | 1.19 (0.784) | 0.77 (0.790) | 1.10 (0.861) |
14 | 0.2 | 52.6 | 1.45 (0.671) | 1.28 (0.774) | 1.22 (0.788) | 1.31 (0.735) |
15 | 1.0 | 40.1 | 1.24 (0.803) | 1.00 (0.995) | 1.04 (0.783) | 1.03 (0.813) |
16 | 0.1 | 18.3 | 1.33 (0.721) | 1.08 (0.886) | 1.03 (0.869) | 1.10 (0.855) |
17 | 0.9 | 33.4 | 1.02 (0.732) | 1.00 (0.892) | 0.77 (0.743) | 0.74 (0.731) |